Apollo Endosurgery - 48 Year Dividend History | APEN

Historical dividend payout and yield for Apollo Endosurgery (APEN) since 1971. The current TTM dividend payout for Apollo Endosurgery (APEN) as of April 24, 2019 is $0.00. The current dividend yield for Apollo Endosurgery as of April 24, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.077B $0.061B
Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $105.305B 23.73
Fresenius Medical Care AG KGaA (FMS) Germany $24.499B 16.77
Teleflex (TFX) United States $12.907B 28.27
STERIS (STE) United Kingdom $10.634B 27.33
Cantel Medical (CMD) United States $2.737B 27.22
Luminex (LMNX) United States $1.004B 45.55
Mesa Laboratories (MLAB) United States $0.886B 36.23